The Liver Imaging Reporting and Data System (LI-RADS) is composed of four individual
algorithms intended to standardize the lexicon, as well as reporting and care, in patients with …

“How to perform contrast-enhanced ultrasound (CEUS)” provides general advice on the use
of ultrasound contrast agents (UCAs) for clinical decision-making and reviews technical …

The present, updated document describes the fourth iteration of recommendations for the
hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European …

The Liver Imaging Reporting and Data System (LI-RADS®) is a comprehensive system for
standardizing the terminology, technique, interpretation, reporting, and data collection of …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Background American College of Radiology contrast agent–enhanced US Liver Imaging
Reporting and Data System (CEUS LI-RADS) was developed to improve the accuracy of …

The first edition of the guidelines for the use of ultrasound contrast agents was published in
2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected …

Contrast-enhanced US (CEUS) has an important role as a supplement to CT or MRI in
clinical practice. The main established utilizations are in the liver and the kidney. The …

Background US contrast agents are gas-filled microbubbles (MBs) that can be locally
destroyed by using external US. Among other bioeffects, US-triggered MB destruction, also …

In 2017, the American College of Radiology introduced the US Liver Imaging Reporting and
Data System (LI-RADS) as a framework for US surveillance of patients at risk for developing …